234 related articles for article (PubMed ID: 31609022)
1. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources.
Tavakoli M; Rivero-Menendez O; Abastabar M; Hedayati MT; Sabino R; Siopi M; Zarrinfar H; Nouripour-Sisakht S; van der Lee H; Valadan R; Meletiadis J; Yazdani Charati J; Seyedmousavi S; Alastruey-Izquierdo A
Mycoses; 2020 Jan; 63(1):78-88. PubMed ID: 31609022
[TBL] [Abstract][Full Text] [Related]
2. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
[TBL] [Abstract][Full Text] [Related]
3. Genetic Diversity and
Taghizadeh-Armaki M; Hedayati MT; Ansari S; Omran SM; Saber S; Rafati H; Zoll J; van der Lee HA; Melchers WJG; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264849
[No Abstract] [Full Text] [Related]
4. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
[TBL] [Abstract][Full Text] [Related]
5. Species Identification and
Imbert S; Normand AC; Ranque S; Costa JM; Guitard J; Accoceberry I; Bonnal C; Fekkar A; Bourgeois N; Houzé S; Hennequin C; Piarroux R; Dannaoui E; Botterel F
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439956
[No Abstract] [Full Text] [Related]
6. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.
Castro C; Galán-Sanchez F; Linares MJ; Tejero R; Ruiz M; Serrano ML; Rodríguez-Iglesias M; Martín-Mazuelos E;
Med Mycol; 2019 Jun; 57(4):412-420. PubMed ID: 30289467
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
Reichert-Lima F; Lyra L; Pontes L; Moretti ML; Pham CD; Lockhart SR; Schreiber AZ
Mycoses; 2018 Jun; 61(6):360-365. PubMed ID: 29468746
[TBL] [Abstract][Full Text] [Related]
8. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Escribano P; Peláez T; Recio S; Bouza E; Guinea J
Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal susceptibility profile and genotypic characterization of clinical Aspergillus isolates in Eastern China on behalf of Eastern China Invasive Fungi Infection Group.
Lin H; Guo J; Li Y; Xiao C; Hu L; Chen H; Lu X; Wu W
Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37580143
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
11. Sequence analysis of isolates of Aspergillus from patients with chronic and allergic aspergillosis reveals a spectrum of cryptic species.
Bongomin F; Moore CB; Masania R; Rowbotham E; Alastruey-Izquierdo A; Novak-Frazer L; Richardson MD
Future Microbiol; 2018 Nov; 13():1557-1563. PubMed ID: 30417667
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
Amorim A; Guedes-Vaz L; Araujo R
Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
[TBL] [Abstract][Full Text] [Related]
13. Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two
Lyskova P; Hubka V; Svobodova L; Barrs V; Dhand NK; Yaguchi T; Matsuzawa T; Horie Y; Kolarik M; Dobias R; Hamal P
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437620
[TBL] [Abstract][Full Text] [Related]
14. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.
Badiee P; Boekhout T; Zarei Mahmoudabadi A; Mohammadi R; Ayatollahi Mousavi SA; Najafzadeh MJ; Soltani J; Hashemi J; Diba K; Ghadimi-Moghadam A; Salimi-Khorashad AR; Shokohi T; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Jun; 10(3):e0253921. PubMed ID: 35579442
[TBL] [Abstract][Full Text] [Related]
17. Molecular identification of clinical and environmental avian Aspergillus isolates.
Sabino R; Burco J; Valente J; Veríssimo C; Clemons KV; Stevens DA; Tell LA
Arch Microbiol; 2019 Mar; 201(2):253-257. PubMed ID: 30627760
[TBL] [Abstract][Full Text] [Related]
18. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
[TBL] [Abstract][Full Text] [Related]
20. Species diversity of Aspergillus section Versicolores in clinical samples and antifungal susceptibility.
Siqueira JP; Sutton DA; García D; Gené J; Thomson P; Wiederhold N; Guarro J
Fungal Biol; 2016 Nov; 120(11):1458-1467. PubMed ID: 27742099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]